(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Life Science Industry Banner - Advancing Healthcare Solutions
Mouse Scroll Icon
April 2021

Nuvalent, Inc. Appoints Alexander Drilon to Its Scientific Advisory Board

Nuvalent, Inc. appointed Alexander Drilon, M.D., to its Scientific Advisory Board (SAB). Alexander currently serves as Chief of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center (MSK) and brings deep expertise in early-phase clinical trials for cancer. 
Nuvalent, Inc. is based in Cambridge, Massachusetts, and uses precisely targeted therapies for patients with cancer.